Prosecution Insights
Prosecution Insights
6 pending office actions • 3 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| §102 only | 1 (17%) |
| §112 only | 1 (17%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHMIDT, EMILY LOUISE | 2 | 58.7% | +36.4% |
| MOORE, SUSANNA | 1 | 68.1% | +31.8% |
| LANGE, ERIC A | 1 | 78.8% | +9.6% |
| WENG, KAI H | 1 | 70.9% | +17.1% |
| BRAUN, MADELINE E | 1 | 68.0% | +24.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18233390 | SOLID STATE FORMS OF LUMATEPERONE DITOSYLATE SALT | MOORE, SUSANNA | 79d overdue |
| 18007821 | SOLID STATE FORMS OF ENSARTINIB AND ENSARTINIB SALTS | BRAUN, MADELINE E | 56d overdue |
| 18023408 | VIAL ADAPTOR WITH VALVE | WENG, KAI H | 52d overdue |
| 18064437 | INJECTION SPRING FOR AGED PREFILLED SYRINGE AND AUTO INJECTOR | SCHMIDT, EMILY LOUISE | 30d overdue |
| 17278123 | INJECTION SPRING FOR AGED PREFILLED SYRINGE AND AUTO INJECTOR | SCHMIDT, EMILY LOUISE | 17d overdue |
| Art Unit | Apps |
|---|---|
| 3783 | 3 |
| 1624 | 2 |
| 3781 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18233390 | SOLID STATE FORMS OF LUMATEPERONE DITOSYLATE SALT | MOORE, SUSANNA | 1624 | Other | Non-Final OA | 79d overdue | Pending | Aug 14, 2023 |
| 18037973 | RATE-LIMITED SYRINGE | LANGE, ERIC A | 3783 | §103 | Non-Final OA | 84d overdue | Pending | May 19, 2023 |
| 18023408 | VIAL ADAPTOR WITH VALVE | WENG, KAI H | 3781 | §102 | Final Rejection | 52d overdue | Pending | Feb 27, 2023 |
| 18064437 | INJECTION SPRING FOR AGED PREFILLED SYRINGE AND AUTO INJECTOR | SCHMIDT, EMILY LOUISE | 3783 | §103 | Final Rejection | 30d overdue | Pending | Dec 12, 2022 |
| 18007821 | SOLID STATE FORMS OF ENSARTINIB AND ENSARTINIB SALTS | BRAUN, MADELINE E | 1624 | §112 | Final Rejection | 56d overdue | Pending | Dec 02, 2022 |
| 17278123 | INJECTION SPRING FOR AGED PREFILLED SYRINGE AND AUTO INJECTOR | SCHMIDT, EMILY LOUISE | 3783 | §103 | Final Rejection | 17d overdue | Pending | Mar 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial